How should unbranched nucleotide sequences be presented in patent applications?

How should unbranched nucleotide sequences be presented in patent applications?

According to MPEP 2421.02, unbranched nucleotide sequences in patent applications must be presented as follows:

• They must be listed using a single letter code for nucleotide bases.
• Sequences with 10 or more nucleotides must be represented in the sequence listing.
• Each sequence must be assigned a separate sequence identifier (SEQ ID NO).

The MPEP states: “Unbranched nucleotide sequences of 10 or more residues and unbranched, non-D amino acid sequences of 4 or more residues, provided that there are at least 10 nucleotides or 4 amino acids within the defined sequence, are required to be included in the sequence listing.” This ensures clarity and standardization in the presentation of genetic information within patent applications.

To learn more:

• nucleotide sequences
• patent applications
• sequence listing
• SEQ ID NO